Safety and Immunogenicity Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

ACYW135 Meningococcal Polysaccharide Vaccine Clinical Trial

Status Enrolling by invitation

Clinical Trial Summary

This study evaluates the safety and immunogenicity of the ACYW135 Meningococcal Polysaccharide Vaccine in population aged 2-50 years old. Subjects will be divided into 3 group according to their age, receiving the test vaccine and the control vaccine at the proportion of 1:1 randomly. Each age group has 400 subjects, 1200 in total.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

• ACYW135 Meningococcal Polysaccharide Vaccine

• NCT number: NCT02869672
• Study type: Interventional
• Source: Beijing Chaoyang District Centre for Disease Control and Prevention
• Status: Enrolling by invitation
• Phase: Phase 3
• Start date: July 2016